Is the level of knowledge a predictor of rational antibiotic use in Serbia?

Autor: Olga J Horvat, Ana D Tomas, Milica M Paut Kusturica, Alisa V Savkov, Dragica U Bukumirić, Zdenko S Tomić, Ana J Sabo

Publikováno v: PLoS ONE, Vol 12, Iss 7, p e0180799 (2017)

The objective of this study was to investigate the knowledge, attitudes and behavior regarding antibiotics of the general population.The study sample consisted of adult subjects who consulted general practitioners at health centers in Serbia and agre

Externí odkaz: https://doaj.org/article/e2925a9e35ef420a9c3b31e8c71d020f

Increase and Change in the Pattern of Antibiotic Use in Serbia (2010–2019)

Autor: Ana Tomas, Zdenko Tomić, Nebojša Pavlović, Nebojša Stilinović, Milica M. Paut-Kusturica, Tihomir Dugandžija, Olga Horvat, Ana Sabo

Publikováno v: Antibiotics
Volume 10
Issue 4
Antibiotics, Vol 10, Iss 397, p 397 (2021)

The aim of this study was to determine and describe trends in antibiotics utilization in Serbia over a ten-year period. Data were retrieved from publicly available annual reports (2010–2019). The results were expressed as Defined Daily Dose (DDD) p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::660a254025d2f5a3215b51956de53023

An Insight on Differences in Availability and Reimbursement of Orphan Medicines Among Serbia, Bulgaria and Sweden

Autor: Milica M. Paut-Kusturica, Bojan Stanimirov, M. Stojancevic, Momir Mikov, Assena Stoimenova, Svetlana Goločorbin-Kon, Nebojša Pavlović

Publikováno v: Biotechnology & Biotechnological Equipment. 26:3236-3241

In the European Union (EU), rare diseases are defined as life-threatening or chronically debilitating diseases with prevalence lower than five in 10,000 inhabitants. Although individually rare, together, rare diseases affect a significant part of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c0b039ae8433f38538d7983e7635507a
https://doi.org/10.5504/bbeq.2012.0085

Comprehensive Analysis of Antioxidant and Hepatoprotective Properties of Morus nigra L.

Autor: Vukmirović S; Department of Pharmacology and Toxicology, Faculty of Medicine Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia., Ilić V; Department of Pharmacology and Toxicology, Faculty of Medicine Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia., Tadić V; Department for Pharmaceutical Research and Development, Institute for Medicinal Plant Research 'Dr. Josif Pancic', Tadeusa Koscuska 1, 11000 Belgrade, Serbia., Čapo I; Department of Histology and Embryology, Medical Faculty of Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia., Pavlović N; Department of Pharmacy, Faculty of Medicine Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia., Tomas A; Department of Pharmacology and Toxicology, Faculty of Medicine Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia., Paut Kusturica M; Department of Pharmacology and Toxicology, Faculty of Medicine Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia., Tomić N; Institute of Emergency Medicine, Clinical Center of Vojvodina, Novi Sad, 21000, Serbia.; Faculty of Medicine Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia., Maksimović S; Department of Organic Chemical Technology, Faculty of Technology and Metallurgy, University of Belgrade, Karnegijeva 4, P.O. Box 3503, 11120 Belgrade, Serbia., Stilinović N; Department of Pharmacology and Toxicology, Faculty of Medicine Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia.

Publikováno v: Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2023 Feb 04; Vol. 12 (2). Date of Electronic Publication: 2023 Feb 04.

Survey of the Knowledge, Attitudes and Practice towards Antibiotic Use among Prospective Antibiotic Prescribers in Serbia.

Autor: Horvat O; Faculty of Medicine, Department of Pharmacology Toxicology and Clinical Pharmacology, University of Novi Sad, 21000 Novi Sad, Serbia., Petrović AT; Faculty of Medicine, Department of Pharmacology Toxicology and Clinical Pharmacology, University of Novi Sad, 21000 Novi Sad, Serbia., Paut Kusturica M; Faculty of Medicine, Department of Pharmacology Toxicology and Clinical Pharmacology, University of Novi Sad, 21000 Novi Sad, Serbia., Bukumirić D; Institute of Public Health 'Dr Milan Jovanovic Batut', 11000 Belgrade, Serbia., Jovančević B; Faculty of Medicine, Department of Pharmacology Toxicology and Clinical Pharmacology, University of Novi Sad, 21000 Novi Sad, Serbia., Kovačević Z; Faculty of Agriculture, Department of Veterinary Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.

Publikováno v: Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2022 Aug 10; Vol. 11 (8). Date of Electronic Publication: 2022 Aug 10.